Drew Fine
Marketing Lead of Dermal Fillers
Galderma
Double Launch Master
When Galderma acquired the rights from Valeant Pharmaceuticals to commercialize Restylane, among other corrective and aesthetic products, it meant Drew Fine was on the clock—and the clock was already ticking. The recently approved Restylane Silk consumer launch was scheduled to occur within months. And at the same time, Restylane Lyft was in the final approval stage for a new indication, which meant Galderma would likely launch two products within one year’s time. Drew had to hit the ground running.
He started by assembling a team including five key agency partners, and ensuring that everyone involved—from regulatory to sales to supplies—knew what to do to ensure a seamless launch. And thanks to Drew’s keen ability to balance timelines, people, and processes, he was able to establish and maintain a full-scale effort that led to the successful launch of two products—and created a rich host of assets in the process.
For example, under Drew’s leadership, restylanesilk.com was launched in just 31 days. It went on to win industry-wide recognition while also winning over consumers—thousands of visitors engage with the site on a monthly basis, performing well above industry averages. Drew also led the creation of both an award-winning HCP campaign and a DTC pilot for Restylane Silk, including print and digital placements in four key markets. All told, the efforts to support Silk surpassed initial sales goals. And when Restylane Lyft launched a few short months later, Drew incorporated learnings from the Silk strategy—leading to another successful brand launch within one year’s time.
“Drew was the guiding force behind the success of launching both Silk and Lyft,” says Alex Tudoran, Digital Marketing Lead for Galderma Aesthetics and Correctives. “He led the teams in a focused manner and also shared successes along the way to keep us all motivated toward the end goal and excited about working on the brands.”
